Startups, growth and SaaS strategy.
Global Markets Slide as Geopolitical Tensions Drive Oil and Bond Yields Global equity markets faced significant downward pressure as escalating tensions in the Middle East fueled...
Stocks in News: Sun Pharma, Tata Motors, and Voltas Lead Key Moves Indian markets ended their five session winning streak on Friday, closing lower as a broad based sell off in the...
Global Markets Retreat as Middle East Tensions Drive Oil and Bond Yields Up Global equity markets faced significant headwinds on Monday as escalating tensions in the Middle East f...
Economy Shows No Signs of Overheating, Says MPC Member Saugata Bhattacharya As India navigates a complex landscape of fluctuating input costs and global supply chain disruptions,...
Stocks in News: Sun Pharma, Tata Motors, Voltas, and Tech Mahindra Lead Indian markets snapped a five session winning streak on Friday, ending lower as a broad based sell off in t...
Saugata Bhattacharya: Little Sign of Economy Overheating Amid Inflation Risks Monetary Policy Committee (MPC) external member Saugata Bhattacharya suggests that despite rising inf...
Market Update: Sun Pharma, Tata Motors, and Voltas Lead Key Corporate Moves Indian markets ended their five session winning streak on Friday as a broad based sell off, particularl...
Market Update: Sun Pharma, Tata Motors, and Voltas Lead Stock News Indian markets ended a five session winning streak on Friday as a broad based sell off, particularly in the IT s...
Is the Indian Economy Overheating? Saugata Bhattacharya Weighs In As the Reserve Bank of India (RBI) navigates a complex landscape of fluctuating crude oil prices and shifting inf...
Why India’s Economy Shows Little Sign of Overheating, Says Saugata Bhattacharya Monetary Policy Committee (MPC) external member Saugata Bhattacharya provides critical insights int...
Stocks in Focus: Sun Pharma, Tata Motors, Voltas, and More Indian markets ended their five session winning streak on Friday as a broad based sell off, particularly in the IT secto...
Can Jio and NSE IPOs Repeat the Iconic Maruti Suzuki Feat? The Indian primary market is standing on the precipice of a historic moment as the long awaited IPOs of Jio Platforms an...
Beyond the AI Hype: Why Old Economy Stocks Are Leading US Markets While the global investment narrative remains obsessed with AI giants and semiconductor surges, recent market dat...
Carlyle Targets $1 Billion Raise via Major Auto and Healthcare IPOs Global private equity powerhouse Carlyle is gearing up for a massive liquidity event in India, targeting nearly...
Beyond the AI Hype: Why Old Economy Stocks are Surging in the US The global investment narrative has long been dominated by tech giants like the "Magnificent Seven" and the emergi...
Carlyle Eyes $1 Billion Fundraising via Auto and Healthcare IPOs Global private equity giant Carlyle is gearing up for a massive liquidity event in India, planning to raise approx...
Can Jio and NSE IPOs Repeat the Historic Maruti Suzuki Feat? The Indian primary market is bracing for two of its most anticipated listings: Jio Platforms and the National Stock Ex...
Will Jio and NSE IPOs Replicate the Iconic Maruti Suzuki Success? The Indian primary market is bracing for two of its most anticipated listings: Jio Platforms and the National Sto...
Carlyle Eyes $1 Billion Raise via Major Auto and Healthcare IPOs Global private equity giant Carlyle is preparing for a massive liquidity event in India, targeting a combined $1 b...
Can Jio and NSE IPOs Repeat the Historic Maruti Success? The Indian primary market is bracing for two of its most anticipated offerings: Jio Platforms and the National Stock Excha...
FPIs Temper Cash Selling, But Derivatives Bets Signal Caution in India While Foreign Portfolio Investors (FPIs) have slowed their aggressive selling in the Indian cash market, the...
Beyond Token Maxxing: Why IT Firms are Prioritizing Real DEI Impact The era of "token maxxing"—the practice of hiring diverse candidates solely to meet numerical quotas or improve...
Semaglutide Market Faces Slump as Excess Inventory Hits ₹100 Crore The much anticipated boom in the Indian semaglutide therapy market has encountered a significant reality check f...
Beyond Token Maxxing: Why Indian IT Firms are Pivoting to Real DEI For years, Diversity, Equity, and Inclusion (DEI) in the Indian IT sector was often criticized as "token maxxing...